GL1X · GenesisL1 explorer

Research workbench

Crystal structure of BRD9 bromodomain in complex with a substituted valerolactam quinolone ligand

Analyse Crystal structure of BRD9 bromodomain in complex with a substituted… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4Z6I
Type
protein
Length
226 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bromodomain-containing protein 9
UniProt
Q9H8M2
Ligands
4L3
Pockets
3 · best druggability 0.43

Structure

x-ray diffraction · 1 distinct chain · 64% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBromodomain-containing protein 9protein11364% helix, 0% strandQ9H8M2

Ligands and binding sites

  • 4L3 · tert-butyl [(2R,3S)-1-(1,4-dimethyl-2-oxo-1,2-dihydroquinolin-7-yl)-6-oxo-2-phenylpiperidin-3-yl]carbamate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1610.430.82144L3
2720.420.80174L3
3630.310.7518empty

Interfaces

1 interface between chains.

  • A–B · 896 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 4Z6I · Crystal structure of BRD9 bromodomain in complex with a substituted valerolactam… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H8M2 · AlphaFold monomer V2.0 prediction for bromodomain-containing protein 9 (Q9H8M2) · a predicted model of the same protein · chain B against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.